The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs
Kotsopoulos, Nikolaos, Connolly, Mark P., Willis, Michael, Nilsson, Andreas, Ericsson, Åsa, Baker‐Knight, James
Published in Diabetes, obesity & metabolism (01.06.2022)
Published in Diabetes, obesity & metabolism (01.06.2022)
Get full text
Journal Article
Effect of once‐weekly subcutaneous semaglutide 2.4 mg on weight‐ and health‐related quality of life in an East Asian population: Patient‐reported outcomes from the STEP 6 trial
Kolotkin, Ronette L., Jeppesen, Ole Kleist, Baker‐Knight, James, Lee, Sang Yeoup, Tokita, Asako, Kadowaki, Takashi
Published in Clinical obesity (01.08.2023)
Published in Clinical obesity (01.08.2023)
Get full text
Journal Article
Impact of BMI and comorbidities on efficacy of once‐weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial
McGowan, Barbara M., Houshmand‐Oeregaard, Azadeh, Laursen, Peter Nørkjær, Zeuthen, Niels, Baker‐Knight, James
Published in Obesity (Silver Spring, Md.) (01.04.2023)
Published in Obesity (Silver Spring, Md.) (01.04.2023)
Get full text
Journal Article
Assessing economic investment required to scale up bariatric surgery capacity in England: a health economic modelling analysis
Baker-Knight, James, Pournaras, Dimitri J, Mahawar, Kamal, Welbourn, Richard, Li, Yuxin, Sharma, Yuvraj, Guerra, Ines, Tahrani, Abd
Published in BMJ open (31.07.2024)
Published in BMJ open (31.07.2024)
Get full text
Journal Article
An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression
Lingvay, Ildiko, Bauer, Robert, Baker-Knight, James, Lawson, Jack, Pratley, Richard
Published in The journal of clinical endocrinology and metabolism (19.04.2022)
Published in The journal of clinical endocrinology and metabolism (19.04.2022)
Get full text
Journal Article
Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
McEwan, Phil, Baker-Knight, James, Ásbjörnsdóttir, Björg, Yi, Yunni, Fox, Aimee, Wyn, Robin
Published in The European journal of health economics (01.03.2023)
Published in The European journal of health economics (01.03.2023)
Get full text
Journal Article
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting
Capehorn, Matthew, Hallén, Nino, Baker-Knight, James, Glah, Divina, Hunt, Barnaby
Published in Diabetes therapy (01.02.2021)
Published in Diabetes therapy (01.02.2021)
Get full text
Journal Article
The Economic Burden of Insulin-Related Hypoglycemia in Spain
Parekh, Witesh, Hoskins, Nicki, Baker-Knight, James, Ramirez de Arellano, Antonio, Mezquita Raya, Pedro
Published in Diabetes therapy (01.08.2017)
Published in Diabetes therapy (01.08.2017)
Get full text
Journal Article
Assessing the health and economic burden of obesity-related complications in East-Asian populations: implementation of risk equations in the Core Obesity Model for Japan and model validation
Tatsuno, Ichiro, Gerlier, Laetitia, Olivieri, Anamaria-Vera, Baker-Knight, James, Lamotte, Mark
Published in BMJ Public Health (14.07.2024)
Published in BMJ Public Health (14.07.2024)
Get full text
Journal Article
The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System
Parekh, Witesh, Streeton, Sophie E., Baker-Knight, James, Montagnoli, Roberta, Nicoziani, Paolo, Marchesini, Giulio
Published in Diabetes therapy (01.06.2018)
Published in Diabetes therapy (01.06.2018)
Get full text
Journal Article
Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain
Parekh, Witesh, Hoskins, Nicki, Baker-Knight, James, Ramirez de Arellano, Antonio, Mezquita Raya, Pedro
Published in Diabetes therapy (01.10.2017)
Published in Diabetes therapy (01.10.2017)
Get full text
Journal Article